Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 145 Total
AUGX - Augmedix Inc - Stock Price Chart
TickerAUGX [NASD]
CompanyAugmedix Inc
CountryUSA
IndustryHealth Information Services
Market Cap56.07MEPS (ttm)-0.43
P/E-EPS this Y-18.64%
Forward P/E-EPS next Y18.10%
PEG-EPS past 5Y62.58%
P/S1.15EPS next 5Y-
P/B3.14EPS Q/Q12.31%
Dividend-Sales Q/Q39.91%
Insider Own10.23%Inst Own76.12%
Insider Trans27.11%Inst Trans0.68%
Short Float3.84%EarningsMay 13/a
Analyst Recom1.67Target Price5.68
Avg Volume385.62K52W Range2.22 - 6.25
May-14-24Downgrade Evercore ISI Outperform → In-line $5 → $1.50
May-14-24Downgrade Maxim Group Buy → Hold $5
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shakil IanCHIEF STRATEGY OFFICERApr 15 '24Option Exercise0.865004303,500Apr 16 09:07 PM
Shakil IanCHIEF STRATEGY OFFICERApr 15 '24Sale3.805001,9003,000Apr 16 09:07 PM
Shakil IanCHIEF STRATEGY OFFICERApr 12 '24Option Exercise0.8619,54416,80822,544Apr 15 09:15 PM
Shakil IanCHIEF STRATEGY OFFICERApr 12 '24Sale3.8219,54474,5903,000Apr 15 09:15 PM
Shakil IanCHIEF STRATEGY OFFICERApr 11 '24Option Exercise0.8624,77821,30927,778Apr 11 08:30 PM
NOTV - Inotiv Inc - Stock Price Chart
TickerNOTV [NASD]
CompanyInotiv Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap54.67MEPS (ttm)-1.29
P/E-EPS this Y82.01%
Forward P/E-EPS next Y25.79%
PEG-EPS past 5Y-184.24%
P/S0.09EPS next 5Y-
P/B0.22EPS Q/Q82.49%
Dividend-Sales Q/Q10.38%
Insider Own10.83%Inst Own17.64%
Insider Trans2.21%Inst Trans-9.15%
Short Float4.92%EarningsMay 15/a
Analyst Recom1.67Target Price12.92
Avg Volume495.69K52W Range1.61 - 11.42
May-14-24Downgrade Jefferies Buy → Hold $11.50 → $3.75
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Beattie John GregoryChief Operating OfficerDec 14 '23Buy3.1247,966149,836111,761Dec 15 05:33 PM
Garrett MichaelChief Commercial OfficerDec 14 '23Buy2.835,00014,14516,467Dec 15 05:33 PM
SHIM - Shimmick Corp. - Stock Price Chart
TickerSHIM [NASD]
CompanyShimmick Corp.
CountryUSA
IndustryEngineering & Construction
Market Cap61.63MEPS (ttm)-
P/E-EPS this Y-401.04%
Forward P/E-EPS next Y93.77%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.58EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own92.25%Inst Own8.63%
Insider Trans0.00%Inst Trans-
Short Float8.62%EarningsMay 13/a
Analyst Recom3.00Target Price3.75
Avg Volume93.49K52W Range2.15 - 7.99
May-14-24Downgrade ROTH MKM Buy → Neutral $9 → $3.50
May-14-24Downgrade Craig Hallum Buy → Hold
Shimmick Corp. engages in the provision of water and other critical infrastructure solutions. The company was founded in 1990 and is headquartered in Irvine, CA.
AKYA - Akoya Biosciences Inc - Stock Price Chart
TickerAKYA [NASD, RUT]
CompanyAkoya Biosciences Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap143.20MEPS (ttm)-1.47
P/E-EPS this Y28.71%
Forward P/E-EPS next Y37.75%
PEG-EPS past 5Y-37.60%
P/S1.53EPS next 5Y-
P/B4.37EPS Q/Q2.69%
Dividend-Sales Q/Q-14.29%
Insider Own55.63%Inst Own29.70%
Insider Trans-0.14%Inst Trans3.88%
Short Float4.73%EarningsMay 13/a
Analyst Recom1.38Target Price6.71
Avg Volume163.14K52W Range3.04 - 8.80
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McKelligon BrianPresident and CEOMar 20 '24Option Exercise0.307,5002,272239,368Mar 22 05:54 PM
McKelligon BrianPresident and CEOMar 20 '24Sale4.977,50037,243231,868Mar 22 05:54 PM
McKelligon BrianPresident and CEOMar 13 '24Sale4.947,50037,035224,368Mar 14 08:41 PM
McKelligon BrianPresident and CEODec 19 '23Option Exercise0.307,5002,272160,063Dec 20 07:16 PM
McKelligon BrianPresident and CEODec 19 '23Sale4.487,50033,566152,563Dec 20 07:16 PM
EAST - Eastside Distilling Inc - Stock Price Chart
TickerEAST [NASD]
CompanyEastside Distilling Inc
CountryUSA
IndustryBeverages - Wineries & Distilleries
Market Cap1.81MEPS (ttm)-6.02
P/E-EPS this Y62.64%
Forward P/E-EPS next Y58.94%
PEG-EPS past 5Y25.05%
P/S0.18EPS next 5Y-
P/B-EPS Q/Q60.72%
Dividend-Sales Q/Q-15.49%
Insider Own30.63%Inst Own0.95%
Insider Trans-3.68%Inst Trans-79.78%
Short Float1.95%EarningsMay 13/a
Analyst Recom1.00Target Price3.50
Avg Volume181.21K52W Range0.84 - 8.22
Eastside Distilling, Inc. engages in the manufacture and marketing of hand-crafted spirits. Its products include bourbon, American whiskey, vodka, and rum. The company was founded by Lenny Gotter on February 11, 2008 and is headquartered in Portland, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVY-NAVARRO ELIZABETH ANNDirectorDec 13 '23Sale1.075,0005,35038,979Dec 13 11:50 AM
FINNSSON ERIC J.DirectorNov 30 '23Sale1.1114,50016,09519,880Dec 01 10:45 AM
FINNSSON ERIC J.DirectorNov 20 '23Sale1.0153153634,380Nov 27 11:52 AM
FINNSSON ERIC J.DirectorJun 20 '23Sale3.603,00010,8004,129Jun 26 09:59 AM
FENC - Fennec Pharmaceuticals Inc - Stock Price Chart
TickerFENC [NASD, RUT]
CompanyFennec Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap198.91MEPS (ttm)0.04
P/E201.65EPS this Y160.33%
Forward P/E10.05EPS next Y101.66%
PEG-EPS past 5Y-2.95%
P/S4.43EPS next 5Y-
P/B66.01EPS Q/Q280.91%
Dividend-Sales Q/Q1413.24%
Insider Own14.60%Inst Own56.11%
Insider Trans-7.72%Inst Trans0.73%
Short Float7.84%EarningsMay 14/b
Analyst Recom1.17Target Price17.03
Avg Volume131.50K52W Range6.30 - 11.92
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Raykov RostyCHIEF EXECUTIVE OFFICERMay 01 '24Sale9.112,43122,152187,471May 02 04:59 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 22 '24Option Exercise2.3122,22351,33522,223Apr 22 07:34 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 22 '24Sale9.3222,223207,0290Apr 22 07:34 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 19 '24Option Exercise2.3122,22251,33322,222Apr 22 07:34 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 19 '24Sale9.3422,222207,4420Apr 22 07:34 PM
REBN - Reborn Coffee Inc - Stock Price Chart
TickerREBN [NASD]
CompanyReborn Coffee Inc
CountryUSA
IndustryRestaurants
Market Cap5.84MEPS (ttm)-2.40
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-267.17%
P/S0.98EPS next 5Y-
P/B3.00EPS Q/Q22.85%
Dividend-Sales Q/Q108.97%
Insider Own56.10%Inst Own0.04%
Insider Trans0.00%Inst Trans-
Short Float3.56%EarningsMar 28/b
Analyst Recom1.00Target Price16.00
Avg Volume1.97M52W Range0.92 - 8.08
Reborn Coffee, Inc. engages in the franchise of retail locations and kiosks of coffee, water, and other beverages. The company was founded by Jay Kim on July 31, 2015 and is headquartered in Brea, CA.
VRPX - Virpax Pharmaceuticals Inc - Stock Price Chart
TickerVRPX [NASD]
CompanyVirpax Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap2.68MEPS (ttm)-14.42
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-20.69%
P/S-EPS next 5Y-
P/B-EPS Q/Q-111.83%
Dividend-Sales Q/Q-
Insider Own25.72%Inst Own0.33%
Insider Trans0.00%Inst Trans-18.21%
Short Float0.91%EarningsMay 13/a
Analyst Recom1.00Target Price20.00
Avg Volume26.40K52W Range2.11 - 11.77
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
JAN - JanOne Inc - Stock Price Chart
TickerJAN [NASD]
CompanyJanOne Inc
CountryUSA
IndustryBiotechnology
Market Cap26.73MEPS (ttm)-3.23
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y23.21%
P/S-EPS next 5Y-
P/B-EPS Q/Q80.97%
Dividend-Sales Q/Q-
Insider Own11.05%Inst Own2.26%
Insider Trans0.00%Inst Trans-7.54%
Short Float2.22%Earnings-
Analyst Recom-Target Price-
Avg Volume278.12K52W Range0.22 - 5.26
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.
CCLD - CareCloud Inc - Stock Price Chart
TickerCCLD [NASD]
CompanyCareCloud Inc
CountryUSA
IndustryHealth Information Services
Market Cap29.50MEPS (ttm)-3.81
P/E-EPS this Y87.23%
Forward P/E-EPS next Y40.48%
PEG-EPS past 5Y-47.21%
P/S0.26EPS next 5Y-
P/B0.71EPS Q/Q94.52%
Dividend-Sales Q/Q-13.46%
Insider Own47.37%Inst Own8.65%
Insider Trans7.88%Inst Trans-5.00%
Short Float0.96%EarningsMay 14/b
Analyst Recom1.00Target Price4.17
Avg Volume1.54M52W Range0.68 - 3.58
CareCloud, Inc. is a healthcare information technology company, which engages in the provision of an integrated suite of proprietary cloud-based electronic health records and practice management solutions. It operates through the Healthcare IT and Practice Management segments. The Healthcare IT segment offers a proprietary web-based suite of services such as practice management applications, certified electronic health records solutions, revenue cycle management services and mobile health applications. The Practice Management segment provides medical practices as well as telemedicine, management, bill-paying and financial advisory services. The company was founded by Mahmud Haq in 1999 and is headquartered in Somerset, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROTH NORMANInterim CFO and ControllerApr 30 '24Option Exercise0.003,500097,925May 02 09:30 PM
Garcia Nathalie GreyGeneral Counsel & SecretaryFeb 15 '24Option Exercise0.004,278012,091Feb 16 09:30 PM
ROTH NORMANInterim CFO and ControllerFeb 06 '24Option Exercise0.007,000096,875Feb 08 09:30 PM
MUNTER CAMERONDirectorFeb 02 '24Option Exercise0.005,0000176,500Feb 05 09:30 PM
BUSQUET ANNEDirectorFeb 02 '24Option Exercise0.005,0000238,888Feb 05 09:30 PM
1234561015